Nomura Holdings
MRNS

Nomura Holdings’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Nomura Holdings’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-58,816
Closed -$369K – 1821
2022
Q4 		$234K Buy
58,816
+58,034
+7,421% +$285K ﹤0.01% 1086
2022
Q3 		$5K Buy
+782
New +$4.82K ﹤0.01% 1579

Other funds holding MRNS

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Nomura Holdings's MRNS Position: Q1 2023 in Review

Nomura Holdings sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2023, closing a stake of 58,816 shares — an estimated $369K sold.

Nomura Holdings first reported a position in MRNS in Q3 2022 and held it in 2 quarters. The position peaked at $234K in Q4 2022. 86 funds tracked by Wall St. Rank hold MRNS as of Q1 2023.

  • Nomura Holdings reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2023 after selling out during the quarter.
  • Nomura Holdings sold 58,816 Marinus Pharmaceuticals, Inc shares in Q1 2023, an estimated $369K.
  • Nomura Holdings first reported a position in Marinus Pharmaceuticals, Inc in Q3 2022 and held it in 2 quarters.
  • Nomura Holdings's Marinus Pharmaceuticals, Inc position peaked at $234K in Q4 2022.
  • 86 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2023.

Based on Nomura Holdings's 13F filing for Q1 2023, filed 15 May 2023.